The European Commission’s recently revealed plans to reverse switch commonly used OTC antimicrobials have come under fire from the German medicines regulator, the Dutch government and associations representing the self-care industry in both countries.
Commenting on the proposal – announced at a recent AESGP Annual Meeting – to make OTC antifungals and antivirals prescription-only as part of measures to combat antimicrobial resistance, the president of German medicines regulator, BfArM said it “overshoots the mark
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?